Surrozen (SRZN) Net Cash Flow (2020 - 2026)

Surrozen (SRZN) recorded quarterly Net Cash Flow of $17.7 million in Q1 2026, up 124.23% quarter-over-quarter from $7.9 million in Q4 2025, and down 73.66% on a YoY basis from $67.1 million in Q1 2025.

Surrozen (SRZN) Net Cash Flow (2020 - 2026) Analysis & Trends

Surrozen's Net Cash Flow history runs 7 years deep, the most recent figure standing at $17.7 million for Q1 2026.

  • In Q1 2026, Net Cash Flow fell 73.66% year-over-year to $17.7 million; the TTM figure through Mar 2026 stood at $5.3 million (down 92.89% YoY), while the FY2025 annual figure was $54.7 million, up 3871.03% from the prior year.
  • Net Cash Flow was $17.7 million for Q1 2026 at Surrozen, up from $7.9 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $67.1 million in Q1 2025 to a low of -$18.8 million in Q1 2022.
  • Historically, Net Cash Flow has averaged $4.4 million across 5 years, with a median of $2.6 million in 2022.
  • The sharpest annual moves came in 2024 and 2025: Net Cash Flow tumbled 379.16% in 2024, then soared 870.17% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at -$796000.0 in 2022, then jumped by 394.1% to $2.3 million in 2023, then surged by 52.97% to $3.6 million in 2024, then soared by 119.99% to $7.9 million in 2025, then jumped by 124.23% to $17.7 million in 2026.
  • The last three Net Cash Flow figures came in at $17.7 million (Q1 2026), $7.9 million (Q4 2025), and -$9.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 2.44 Mn
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 625.70 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -2.44 Mn
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 457.40 Mn
9 Abivax 94.37 Bn 94.37 Bn - 664,983.53
10 Surrozen 225,877.86 -106.68 Mn - 17.67 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 17.67 Mn
Mar 31, 2026 17.67 Mn
Dec 31, 2025 7.88 Mn
Dec 31, 2025 7.88 Mn
Sep 30, 2025 -9.02 Mn
Sep 30, 2025 -9.02 Mn
Jun 30, 2025 -11.24 Mn
Jun 30, 2025 -11.24 Mn
Mar 31, 2025 67.06 Mn
Mar 31, 2025 67.06 Mn
Dec 31, 2024 3.58 Mn
Dec 31, 2024 3.58 Mn
Sep 30, 2024 -6.75 Mn
Sep 30, 2024 -6.75 Mn
Jun 30, 2024 10.43 Mn
Jun 30, 2024 10.43 Mn
Mar 31, 2024 -8.71 Mn
Mar 31, 2024 -8.71 Mn
Dec 31, 2023 2.34 Mn
Dec 31, 2023 2.34 Mn